Ragini Kudchadkar, a medical oncologist and melanoma specialist at Winship Cancer Institute of Emory University, was named chair of the Clinical and Translational Review Committee, the group responsible for scientifically reviewing all proposed cancer clinical trials at Winship.
The FDA Oncologic Drugs Advisory Committee July 25 voted unanimously to set more rigorous standards for new trials for approval of perioperative indications of cancer drugs.
